{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-064094","form_type":"8-K","ticker":"DDD","cik":"0000910638","company_name":"3D SYSTEMS CORP","filed_at":"2025-03-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.766884+00:00","generated_at":"2026-05-24T05:23:08.203144+00:00","sec_items":["2.02","2.05","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"3D Systems FY2024 revenue $440M; Q4 adj EBITDA loss $19.1M; targets breakeven by Q4 2025","bullets":["FY2024 revenue $440M (-10% YoY); Q4 revenue $111M (-3% YoY) with $8.7M reduction from Regenerative Medicine accounting change.","Q4 net loss $33.7M ($0.25 diluted loss); adj EBITDA loss $19.1M vs loss $14.0M YoY.","New restructuring aims for >$50M annualized savings by Q2 2026; expects $12-20M charges.","Geomagic software platform sale for $123M; all regulatory approvals obtained; early April close.","2025 outlook: revenue $420-435M (flat/modest growth ex-Geomagic); target breakeven adj EBITDA by Q4 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-064094","json":"https://secwatch.observer/filing/0001193125-25-064094.json","markdown":"https://secwatch.observer/filing/0001193125-25-064094.md","text":"https://secwatch.observer/filing/0001193125-25-064094.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/910638/000119312525064094/0001193125-25-064094-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/910638/000119312525064094/d940288d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T05:23:08.203144+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e38ec36384ebeb9e3b59701e0df49a6fcaa5cc67","claim":"3D SYSTEMS CORP announced a restructuring with charges of approximately $12 to $20 million.","evidence_excerpt":"of at least $50 million by the end of the second quarter of the Company’s fiscal year ending December 31, 2026. The Company expects to incur aggregate charges of approximately $12 to $20 million predominantly related to employee severance (including certain one-time costs related to employee benefits), one-time capital expenditures, and contract termination","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/910638/000119312525064094/0001193125-25-064094-index.htm","confidence":0.9,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"restructuring"},{"label":"Charge","value":"approximately $12 to $20 million"}],"fact_type":"restructuring_charge"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}